Abstract:Background: Although immune checkpoint inhibitors (ICIs) have achieved important breakthroughs in the treatment of liver cancer, most hepatocellular carcinoma (HCC) patients do not respond to ICIs, and their clinical outcome remains unsatisfactory. The tumor microenvironment (TME), which contains immune cells and other molecules, probably influences both the prognosis and the response to immunotherapy in HCC. Here, using integrated bioinformatics analyses, we identified key molecules (immune cells and immune-r… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.